About Rhythm Pharmaceuticals
Rhythm Pharmaceuticals is not your typical biopharmaceutical company. We are on a mission to transform the lives of patients and families facing rare neuroendocrine diseases with our innovative medicines. We are inspired by the courage of patients and caregivers as they navigate the journey of advocacy, challenging norms, asking bold questions, and seeking answers for them.
Our Unique Approach
At Rhythm, we strive for excellence every day by embracing adaptability, continuous learning, and a tenacious spirit to overcome barriers together. Our lead asset, IMCIVREE® (setmelanotide), is leading the way in treating hyperphagia and early-onset severe obesity caused by MC4R pathway diseases. With a global reach, a commitment to clinical research, and a focus on precision medicine, Rhythm Pharmaceuticals is dedicated to expanding access to life-changing treatments for patients worldwide.
